Completed PHASE1 INTERVENTIONAL 2-arm NCT04126668

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

A Pharmacokinetic Study in Chinese Healthy Male and Female Volunteers to Investigate the Effect of Food on the Pharmacokinetics of CM082 Tablet.

Sponsor: AnewPharma

Conditions Advanced Malignant Solid Tumors

Interventions CM082 with fed or fasting

Updated 6 times since 2019 Last updated: May 20, 2020 Started: Dec 19, 2019 Primary completion: Jan 16, 2020 Completion: Jan 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Advanced Malignant Solid Tumors and is currently completed. AnewPharma leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Feb 2020 — Jun 2020 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Nov 2019 — Feb 2020 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AnewPharma

Data source: AnewPharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China